342 related articles for article (PubMed ID: 29693182)
1. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
2. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
3. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
5. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
6. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
7. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
8. Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.
Ye F; Chen Y; Xia L; Lian J; Yang S
Biochem Biophys Res Commun; 2018 Mar; 497(2):639-645. PubMed ID: 29453983
[TBL] [Abstract][Full Text] [Related]
9. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
10. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
11. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
12. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
14. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.
Wang L; Fan Y; Zhang L; Li L; Kuang G; Luo C; Li C; Xiang T; Tao Q; Zhang Q; Ying J
FASEB J; 2019 Jan; 33(1):254-263. PubMed ID: 29957056
[TBL] [Abstract][Full Text] [Related]
15. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
16. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
17. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
[TBL] [Abstract][Full Text] [Related]
18. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
[TBL] [Abstract][Full Text] [Related]
20. Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway.
Lu Y; Zhang Y; Wang X; Zhang H; Zhu Y; Zhang J; Sha H; Zou R; Gan Y; Sui Y; Wang J; Du T; Wu J; Feng J
Dis Markers; 2023; 2023():1702125. PubMed ID: 37457886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]